Clinical Trial Update: Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced Cancers [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports on a study of liposomal doxorubicin combined with PSC-833 in AIDS-related Kaposi's sarcoma and other advanced cancers, which h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposi Sarcoma

Drugs mentioned

• Doxil (liposomal doxorubicin)
• PSC 833 (valspodar)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Sarcoma, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Status: COMPLETED